- Thinly traded nano cap Oragenics (OGEN +44.8%) is up on a healthy 35x surge in volume. Shares were up 116% before retracing. No particular news accounts for the action.
- At the end of December, it had $6.2M in quick assets. Operations consumed $6.4M in 2017 so a capital raise will be needed at some point.
- The company's lead candidate is Phase 2-stage AG013 for the treatment of oral mucositis.
- Previously: Oragenics' lead product candidate Fast Track'd in U.S. for oral mucositis; shares up 19% (Nov. 21, 2016)
Oragenics up 45%
Recommended For You
More Trending News
About OGEN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
OGEN | - | - |
Oragenics, Inc. |